| 39.76 -0.59 (-1.46%) | 11-05 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 48.58 |
1-year : | 56.75 |
| Resists | First : | 41.59 |
Second : | 48.58 |
| Pivot price | 34.75 |
|||
| Supports | First : | 35.27 |
Second : | 31.37 |
| MAs | MA(5) : | 35.98 |
MA(20) : | 35.07 |
| MA(100) : | 36.27 |
MA(250) : | 0 | |
| MACD | MACD : | 0.4 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 75.1 |
D(3) : | 56.6 |
| RSI | RSI(14): 69.8  |
|||
| 52-week | High : | 50.87 | Low : | 31.37 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ MDLN ] has closed It is unclear right now based on current values. 63.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 41.63 - 41.84 | 41.84 - 41.98 |
| Low: | 38.45 - 38.72 | 38.72 - 38.89 |
| Close: | 39.37 - 39.78 | 39.78 - 40.04 |
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
Thu, 05 Nov 2026
Medline (NASDAQ:MDLN) Given New $49.00 Price Target at UBS Group - MarketBeat
Thu, 05 Nov 2026
Leerink Partners Forecasts Strong Price Appreciation for Medline (NASDAQ:MDLN) Stock - MarketBeat
Thu, 05 Nov 2026
What Just Happened To Medline Stock? - Yahoo Finance
Wed, 04 Nov 2026
Medline Inc. (MDLN) Stock Forecasts - Yahoo Finance
Wed, 04 Nov 2026
Medline Q3 Earnings Call Highlights - TradingView
Wed, 04 Nov 2026
Medline (MDLN) Shares Surge Over 10% After Q3 Earnings Beat and $1B Buyback Announcement - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 877 (M) |
| Shares Float | 370 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 112 (%) |
| Shares Short | 52,690 (K) |
| Shares Short P.Month | 39,480 (K) |
| EPS | 0.4 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.18 |
| Profit Margin | 2.3 % |
| Operating Margin | 0.8 % |
| Return on Assets (ttm) | 2.4 % |
| Return on Equity (ttm) | 4.9 % |
| Qtrly Rev. Growth | 11.6 % |
| Gross Profit (p.s.) | 8.55 |
| Sales Per Share | 34.12 |
| EBITDA (p.s.) | 2.87 |
| Qtrly Earnings Growth | 262 % |
| Operating Cash Flow | 1,990 (M) |
| Levered Free Cash Flow | 851 (M) |
| PE Ratio | 99.39 |
| PEG Ratio | 0 |
| Price to Book value | 3.01 |
| Price to Sales | 1.16 |
| Price to Cash Flow | 17.52 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|